Dee Mangin

5.3k total citations · 1 hit paper
122 papers, 2.7k citations indexed

About

Dee Mangin is a scholar working on Economics and Econometrics, General Health Professions and Geriatrics and Gerontology. According to data from OpenAlex, Dee Mangin has authored 122 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 57 papers in Economics and Econometrics, 50 papers in General Health Professions and 46 papers in Geriatrics and Gerontology. Recurrent topics in Dee Mangin's work include Health Systems, Economic Evaluations, Quality of Life (49 papers), Chronic Disease Management Strategies (41 papers) and Pharmaceutical Practices and Patient Outcomes (40 papers). Dee Mangin is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (49 papers), Chronic Disease Management Strategies (41 papers) and Pharmaceutical Practices and Patient Outcomes (40 papers). Dee Mangin collaborates with scholars based in Canada, New Zealand and United Kingdom. Dee Mangin's co-authors include Doron Garfinkel, Prasad S. Nishtala, Nagham Ailabouni, June Tordoff, Andrew Wilson, Nicoletta Aimonino Ricauda, Gideon A. Caplan, Cathy Risdon, Joanna Le Noury and Larkin Lamarche and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Cochrane Database of Systematic Reviews.

In The Last Decade

Dee Mangin

114 papers receiving 2.6k citations

Hit Papers

Prevalence of multimorbidity and polypharmacy among adult... 2024 2026 2025 2024 20 40 60

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dee Mangin Canada 25 1.2k 938 817 503 333 122 2.7k
Patrik Midlöv Sweden 34 1.4k 1.2× 576 0.6× 839 1.0× 420 0.8× 381 1.1× 150 3.3k
Andrew L. Gilbert Australia 32 1.3k 1.0× 708 0.8× 553 0.7× 509 1.0× 353 1.1× 94 3.0k
Jenni Ilomäki Australia 26 1.1k 0.9× 600 0.6× 478 0.6× 353 0.7× 185 0.6× 154 2.6k
Dima M. Qato United States 26 855 0.7× 597 0.6× 573 0.7× 412 0.8× 399 1.2× 89 3.3k
Ilene H. Zuckerman United States 35 683 0.6× 656 0.7× 613 0.8× 546 1.1× 359 1.1× 114 3.6k
Rupert Payne United Kingdom 28 851 0.7× 800 0.9× 755 0.9× 884 1.8× 282 0.8× 128 3.6k
Jørund Straand Norway 29 896 0.7× 477 0.5× 620 0.8× 248 0.5× 253 0.8× 125 2.5k
Ingrid Sketris Canada 29 1.1k 0.9× 636 0.7× 568 0.7× 306 0.6× 399 1.2× 158 3.6k
Arlene S. Bierman United States 38 942 0.8× 960 1.0× 1.3k 1.6× 638 1.3× 324 1.0× 127 4.7k
Andreas Sönnichsen Germany 29 825 0.7× 555 0.6× 676 0.8× 424 0.8× 304 0.9× 108 2.8k

Countries citing papers authored by Dee Mangin

Since Specialization
Citations

This map shows the geographic impact of Dee Mangin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dee Mangin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dee Mangin more than expected).

Fields of papers citing papers by Dee Mangin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dee Mangin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dee Mangin. The network helps show where Dee Mangin may publish in the future.

Co-authorship network of co-authors of Dee Mangin

This figure shows the co-authorship network connecting the top 25 collaborators of Dee Mangin. A scholar is included among the top collaborators of Dee Mangin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dee Mangin. Dee Mangin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Al‐Busaidi, Ibrahim S., et al.. (2025). Cefalexin prescribing appropriateness in general practice: an evaluation study. Journal of Primary Health Care. 1 indexed citations
4.
Wallace, Emma, Michelle Flood, Dee Mangin, et al.. (2025). Medications and individual factors associated with serotonin syndrome: a protocol for an overview of reviews. 10. 475–475. 1 indexed citations
5.
Healy, David & Dee Mangin. (2024). Post-SSRI sexual dysfunction: barriers to quantifying incidence and prevalence. Epidemiology and Psychiatric Sciences. 33. e40–e40. 4 indexed citations
6.
Okafor, Charles, Syed Afroz Keramat, Tracy Comans, et al.. (2024). Cost-Consequence Analysis of Deprescribing to Optimize Health Outcomes for Frail Older People: A Within-Trial Analysis. Journal of the American Medical Directors Association. 25(3). 539–544.e2. 5 indexed citations
7.
8.
Mangin, Dee, Larkin Lamarche, Jennifer Salerno, et al.. (2023). Theoretical Underpinnings of a Model to Reduce Polypharmacy and Its Negative Health Effects: Introducing the Team Approach to Polypharmacy Evaluation and Reduction (TAPER). Drugs & Aging. 40(9). 857–868. 6 indexed citations
9.
Mangin, Dee, Larkin Lamarche, Doug Oliver, et al.. (2023). Health TAPESTRY Ontario: A Multi-Site Randomized Controlled Trial Testing Implementation and Reproducibility. The Annals of Family Medicine. 21(2). 132–142. 1 indexed citations
10.
Farrell, Barbara, Lalitha Raman‐Wilms, Cheryl A Sadowski, et al.. (2023). A Proposed Curricular Framework for an Interprofessional Approach to Deprescribing. Medical Science Educator. 33(2). 551–567. 24 indexed citations
11.
Jamieson, Hamish A., Prasad S. Nishtala, Susan Weaver, et al.. (2023). Deprescribing Anticholinergic and Sedative Drugs to Reduce Polypharmacy in Frail Older Adults Living in the Community: A Randomized Controlled Trial. The Journals of Gerontology Series A. 78(9). 1692–1700. 14 indexed citations
12.
Etherton‐Beer, Christopher, Amy Page, Andrew J. McLachlan, et al.. (2022). Deprescribing for older people living in residential aged care facilities: Pharmacist recommendations, doctor acceptance and implementation. Archives of Gerontology and Geriatrics. 107. 104910–104910. 19 indexed citations
13.
Morrow, Richard L., Barbara Mintzes, Patrick C. Souverein, et al.. (2022). Influence of drug safety advisories on drug utilisation: an international interrupted time series and meta-analysis. BMJ Quality & Safety. 31(3). 179–190. 3 indexed citations
14.
Santaguida, Pasqualina, Anne Gilsing, Larkin Lamarche, et al.. (2020). Delphi consensus on core criteria set selecting among health-related outcome measures (HROM) in primary health care. Journal of Clinical Epidemiology. 127. 105–116. 4 indexed citations
16.
Signal, Louise, Jeannine Stairmand, Cheryl Davies, et al.. (2017). A walking stick in one hand and a chainsaw in the other: patients' perspectives of living with multimorbidity.. PubMed. 130(1455). 65–76. 18 indexed citations
19.
Starfield, Bárbara & Dee Mangin. (2010). An international perspective on the basis for payment for performance.. PubMed. 18(6). 399–404. 12 indexed citations
20.
Dowson, C, et al.. (2007). Prevalence of complementary and alternative medicine use in Christchurch, New Zealand: children attending general practice versus paediatric outpatients.. PubMed. 120(1251). U2464–U2464. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026